How to Address the Lack of Commercial Antibodies for Model Organisms? antibodies available commercially at present are mainly intended for protein research from human or relevant mammalian species like rats and mice. Other non-mammalian model organisms, such as rice, Arabidopsis, corn, yeast, fruit flies, nematodes, etc., Published 2 Years Ago by Vivian creative
SARS-CoV-2 Antibodies Protect People from Infection or Reinfection The COVID-19 has changed people's lifestyles, and people are eager to return to their normal lives. This article introduces the contribution of SARS-CoV-2 antibody in preventing and fighting infections. Published 3 Years Ago by Ella Bette
Global Antibodies Market is poised to cross USD 161.897 Billion in 2021 According to the report Global Antibodies Market, published by Market Data Forecast, The Global Market was worth $ 95.217 Billion in 2016 and estimated to reach $ 161.897 Billion by the end of 2021 with a growing potential of 11.20 %.Antibodies are Published 6 Years Ago by MDFtrends
Antibodies Market Set to Deliver Major Revenue Shares during the Forecast Period The global demand for antibodies is expected to remain moderate in the forthcoming years. Increasing prevalence of chronic ailments such as autoimmune diseases, cancer, diabetes and others is encouraging manufacturers to step up investments in R&D Published 4 Years Ago by Arslan
Monoclonal Antibodies Market to Register Substantial Expansion by 2024 Antibodies, which are proteins generated by plasma cells in response to specific antigens, is used for diagnostic and therapeutic purposes. Monoclonal antibodies (mAbs), a type of mono-specific antibodies, are comprised of identical antibody molecules and Published 4 Years Ago by amanjaiswar
